Authors: Robin Arnold, Ankit Kulshrestha, Abheek Bose, Mayur Muley, Anant Kasodekar
The launch of the PUMA 650 surgical robot in the 1980s, initially employed in brain biopsy procedures, ushered in the era of medical robots.1 From then until the present day, remarkable innovations have led to the development of state-of-the-art robots and their seamless integration into diagnosis, surgery, and rehabilitation. These innovations were driven by the shortage of skilled healthcare professionals to meet the growing demand for minimally invasive procedures, and the need to enhance patient outcomes.
The global medical robotics market is poised to grow by 21.3%, reaching $35 billion by 2030.2 This robust growth stands testament to the increasing significance of robotics in shaping the future of healthcare. Robotics not only addresses current challenges but also anticipates the evolving needs of medicine, positioning technology as a driver of more efficient, precise, and patient-centric care.
Complete the form below to download the full article and learn more about the key benefits, barriers and opportunities of robotics in APAC.
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…